Delving into the Latest Updates on Toyo Pharmar Co. Ltd. with Synapse

Studies on aldose reductase inhibitors from natural products. Part III. Studies on aldose reductase inhibitors from medicinal plant of "Sinfito," Potentilla candicans, and further synthesis of their related compounds.

Article

作者: Morita, Naokata ; Imai, Kunihiro ; Shimizu, Mineo ; Nakayama, Hajime ; Ishikura, Masatoshi ; Suzui, Akio ; Ueda, Yutaka ; Terashima, Satoshi

For several years we have screened natural products having aldose reductase (AR) inhibitory activity. 3,3',4-Tri-O-methylellagic acid 4'-sulfate potassium salt (2) was isolated from a Mexican herb "Sinfito" (Potentilla candicans) as a potent AR inhibitory active constituent. 2 was more potent (IC50 = 8.0 x 10(-8)M) than ellagic acid, which is one of the natural inhibitors of AR. So we examined the synthesis of ellagic acid derivatives and found that the sulfate group is one of the important function.

100 项与 Toyo Pharmar Co. Ltd. 相关的药物交易

登录后查看更多信息

100 项与 Toyo Pharmar Co. Ltd. 相关的转化医学

登录后查看更多信息

组织架构

使用我们的机构树数据加速您的研究。

登录

或

查看完整样例数据

管线布局

2024年12月23日管线快照

管线布局中药物为当前组织机构及其子机构作为药物机构进行统计，早期临床1期并入临床1期，临床1/2期并入临床2期，临床2/3期并入临床3期

批准上市

6

1

其他

登录后查看更多信息

当前项目

药物(靶点)	适应症	全球最高研发状态

氟化钠	龋齿更多	批准上市
银氮烷氟化物	牙根龋更多	批准上市
薁磺酸钠/碳酸氢钠	牙龈炎更多	批准上市
杆菌肽/硫酸新霉素 ( 30S subunit )	简单的皮肤和皮肤结构感染(uSSSI) 更多	批准上市
氢氧化铝/氢氧化镁 ( Proton pump )	十二指肠溃疡更多	批准上市